Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1)

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 220-230

  Liang, Shun Hsin ^a   Hassett, Christopher ^a   Omiecinski, Curtis J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; HEPATOCYTE NUCLEAR FACTOR 3; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; EXON; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EPOXIDE HYDROLASES; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSFECTION;

EID: 11244339945     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005579     Document Type: Article

References (42)

1. Alves C, von Dippe P, Amoui M, and Levy D (1993) Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J Biol Chem 268:20148-20155.
2. Arceci RJ, King AA, Simon MC, Orkin SH, and Wilson DB (1993) Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 13:2235-2246.
3. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Gonzalez FJ, Butterworth BE, Borghoff SJ, Everitt JI, et al. (2003) Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzene-induced toxicity. Toxicol Sci 72:201-209.
4. Bossard P and Zaret KS (1998) GATA transcription factors as potentiators of gut endoderm differentiation. Development 125:4909-4917.
5. Charron F, Paradis P, Bronchain O, Nemer G, and Nemer M (1999) Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol Cell Biol 19:4355-4365.
6. Chen CY, Gatto-Konczak F, Wu Z, and Karin M (1998) Stabilization of interleukin-2 MRNA by the C-Jun NH2-terminal kinase pathway. Science (Wash DC) 280:1945-1949.
7. Cho MK and Kim SG (1998) Differential induction of rat hepatic microsomal epoxide hydrolase and RGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. Chem Biol Interact 116:229-245.
8. Davis DL and Burch JB (1996) The chicken vitellogenin II gene is flanked by a GATA factor-dependent estrogen response unit. Mol Endocrinol 10:937-944.
9. Denson LA, McClure MH, Bogue CW, Karpen SJ, and Jacobs HC (2000) HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex. Gene 246:311-320.
10. Fandrich P, Degiuli B, Vogel Bindel U, Arand M, and Oesch F (1995) Induction of rat liver microsomal epoxide hydrolase by its endogenous substrate 16 alpha, 17 alpha-epoxyestra-1,3,5-trien-3-ol. Xenobiotica 25:239-244.
11. Fretland AJ and Omiecinski CJ (2000) Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129:41-59.
12. Gaedigk A, Leeder JS, and Grant DM (1997) Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase. DNA Cell Biol 16:1257-1266.
13. Gregori C, Kahn A, and Pichard AL (1994) Activity of the rat liver-specific aldolase b promoter is restrained by HNF3. Nucleic Acids Res 22:1242-1246.
14. Guenthner TM, Cai D, and Wallin R (1998) Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle. Biochem Pharmacol 55:169-175.
15. Hardwick JP, Gonzalez FJ, and Kasper CB (1983) Transcriptional regulation of rat liver epoxide hydratase, NADPH-cytochrome P-450 oxidoreductase and cytochrome P-450b genes by phenobarbital. J Biol Chem 258:8081-8085.
16. Hartsfield JK Jr, Sutcliffe MJ, Everett ET, Hassett C, Omiecinski CJ, and Saari JA (1998) Assignment 1 of microsomal epoxide hydrolase (EPHX1) to human chromosome 1q42.1 by in situ hybridization. Cytogenet Cell Genet 83:44-45.
17. Hassett C, Aicher L, Sidhu JS, and Omiecinski CJ (1994a) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428.
18. Hassett C, Lin J, Carty CL, Laurenzana EM, and Omiecinski CJ (1997) Human hepatic microsoma expoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337:275-283.
19. Hassett C, Robinson KB, Beck NB, and Omiecinski CJ (1994b) The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 23:433-442.
20. Hassett C, Turnblom SM, DeAngeles A, and Omiecinski CJ (1989) Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA. Arch Biochem Biophys 271:380-389.
21. Honscha W, Oesch F, and Friedberg T (1991) Tissue-specific expression and differential inducibility of several microsomal epoxide hydrolase mRNAs which are formed by alternative splicing. Arch Biochem Biophys 287:380-385.
22. Horton RM, Cai ZL, Ho SN, and Pease LR (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8:528-535.
23. Hsu K, Chang DY, and Maraia RJ (1995) Human signal recognition particle (SRP) Alu-associated protein also binds Alu interspersed repeat sequence RNAs. Characterization of human SRP9. J Biol Chem 270:10179-10186.
24. Huang MC, Li KK, and Spear BT (2002) The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA). DNA Cell Biol 21:561-569.
25. Kaestner KH (2000) The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab 11:281-285.
26. Landry JR, Mager DL, and Wilhelm BT (2003) Complex controls: the role of alternative promoters in mammalian genomes. Trends Genet 19:640-648.
27. Lee WJ, Brennan P, Boffetta P, London SJ, Benhamou S, Rannug A, To-Figueras J, Ingelman-Sundberg M, Shields P, Gaspari L, et al. (2002) Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers 7:230-241.
28. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoebonnie A, Oforiadjei D, et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92:2384-2387.
29. Mertes I, Fleischmann R, Glatt HR, and Oesch F (1985) Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. Carcinogenesis 6:219-223.
30. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Fernandez-Salguero P, Kimura S, and Gonzalez FJ (1999) Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem 274:23963-23968.
31. Molkentin JD (2000) The zinc finger-containing transcription factors GATA-4, -5 and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275:38949-38952.
32. Nanbru C, Lafon I, Audigier S, Gensac MC, Vagner S, Huez G, and Prats AC (1997) Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem 272:32061-32066.
33. Oesch F, Herrero ME, Hengstler JG, Lohmann M, and Arand M (2000) Metabolic detoxification: implications for thresholds. Toxicol Pathol 28:382-387.
34. Omiecinski CJ, Aicher L, Holubkov R, and Checkoway H (1993) Human Peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3:150-158.
35. Philippe J, Morel C, and Prezioso VR (1994) Glucagon gene expression is negatively regulated by hepatocyte nuclear factor 3 beta. Mol Cell Biol 14:3514-3523.
36. Sayer JM, Yagi H, van Bladeren PJ, Levin W, and Jerina DM (1985) Stereoselectivity of microsomal epoxide hydrolase toward diol epoxides and tetrahydroepoxides derived from benz[a]anthracene. J Biol Chem 260:1630-1640.
37. Skoda RC, Demierre A, McBride OW, Gonzalez FJ, and Meyer UA (1988) Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells and chromosomal localization. J Biol Chem 263:1549-1554.
38. Stein I, Itin A, Einat P, Skaliter R, Grossman Z, and Keshet E (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 18:3112-3119.
39. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, and Potter JD (2001) Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10:875-882.
40. Wolf DA, Strobl LJ, Pullner A, and Eick D (1995) Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity. Nucleic Acids Res 23:3373-3379.
41. Zhu J, Shendure J, Mitra RD, and Church GM (2003) Single molecule profiling of alternative pre-MRNA splicing. Science (Wash DC) 301:836-838.
42. Zhu QS, Qian B, and Levy D (2004) Regulation of human microsomal epoxide hydrolase gene (EPHX1) expression by the transcription factor GATA-4. Biochim Biophys Acta 1676:251-260.